IDXX vs A — Key Metrics
| Metric | IDXX (IDEXX LABORATORIES INC) | A (AGILENT TECHNOLOGIES INC) |
|---|---|---|
| Price | 698.47 | 177.33 |
| Market Cap | 55.03 Billion | 49.99 Billion |
| P/E (TTM) | 46.81 | 34.77 |
| P/B (Quarterly) | 28.31 | 5.741 |
| P/S (TTM) | 11.8 | 6.78 |
| Net Profit Margin (TTM) | 25.4 | 19.5 |
| Gross Margin (TTM) | 62.7 | 53.8 |
| ROE (TTM) | 71.2 | 20.5 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Underperform
Underperform
Recommendation Summary
Stock IDXX is projected to greatly underperform the market, stock A is projected to underperform the market. Upfront Recommendation: A.
Financial Metrics
| IDXX | Metrics | A |
|---|---|---|
| $698.47 | Price | $177.33 |
| — | Market Capitalization | — |
| 46.81 | Price to Earnings Ratio | 34.77 |
| 11.8 | Price to Sales | 6.78 |
| 42.65 | Price to FCF Ratio | 39.46 |
| 18.82 | Price to Gross Profit | 12.6 |
| 206.21 | Price to R&D | 103.08 |
| 36.69 | Price to Current Assets | 10.65 |
IDXX vs A at a glance
Idexx Laboratories INC (IDXX) and Agilent Technologies INC (A) are both Diagnostics & Research companies in the Healthcare sector. They are similar in size: $55.0 billion and $50.0 billion in market value.
On trailing-twelve-month figures, IDXX trades at 46.8 times trailing earnings and A at 34.8; net profit margins are 25.4% and 19.5%.
The Upfront Investment model currently rates IDXX Greatly Underperform and A Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.